- Home
- CISS vs IMCC Comparison
CISS vs IMCC Comparison
Compare CISS & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CISS | IMCC |
|---|---|---|
| Founded | 2022 | 1980 |
| Country | Greece | Israel |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2M | 2.2M |
| IPO Year | 2022 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CISS | IMCC |
|---|---|---|
| Price | $0.83 | $0.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 243.6K | 224.2K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $63.88 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.82 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.08 | $0.30 |
| 52 Week High | $5.93 | $7.12 |
Technical Indicators
Market Signals| Indicator | CISS | IMCC |
|---|---|---|
| Relative Strength Index (RSI) | 37.63 | 30.25 |
| Support Level | $0.76 | $0.30 |
| Resistance Level | $1.94 | $1.55 |
| Average True Range (ATR) | 0.05 | 0.06 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 40.96 | 17.19 |
Price Performance
Historical ComparisonAbout CISS C3is Inc.
C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of its fleet is approximately 64,000 dwt.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.